Skopos Labs, Inc. Prime Medicine, Inc. Transaction History

Skopos Labs, Inc.

$330 Million
Q4 2024

A detailed history of Skopos Labs, Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,894 shares of PRME stock, worth $5,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,894

Holding current value

$5,606

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Jan 15, 2025	BUY	$2.64 - $4.46 $5,000 - $8,447	1,894 New	1,894 $5,000

Others Institutions Holding PRME

# of Institutions

127

Shares Held

64.9M

Call Options Held

324K

Put Options Held

64.4K

Alphabet Inc. Mountain View, CA

15.1M
Shares

$44.6 Million
3.99% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.66M
Shares

$16.8 Million
0.21% of portfolio
Black Rock Inc. New York, NY

5.11M
Shares

$15.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$14.5 Million
0.0% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.81M
Shares

$11.3 Million
0.01% of portfolio

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $283M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skopos Labs, Inc. with notifications on news.

Account